Small Cap Feast
Small Cap Feast – 16th September 2016
Dish of the Day:
No primary today
No primary today
Off the Menu:
IPSA (IPSA.L) now a cash shell is to delist today
IPSA (IPSA.L) now a cash shell is to delist today
What’s Cooking in the IPO Kitchen?
Hollywood Bowl — CityAM reports that Hollywood Bowl which delayed its expected July IPO is expected to price the issue shortly.
Biffa — Intention to float announcement states that up to £270m is to be raised to pay down debt and historic landfill tax liability.
Misys — The press reports that the Banking Technology provider owned by Vista Equity Partners is seeking a £5.5bn float in London.
Bacanora Lithium — To list on AIM around 28 Sep as holding company for TSX listed Bacanora Minerals at £100m market cap.
Eco Animal Health (EAH.L) 440p £282.6m
Upbeat AGM statement from the company focused on the development, registration and marketing of pharmaceutical products for animals. Trading this year has started well and the first five months saw sales significantly ahead of the same period last year. Following the “Brexit” vote in June and the weakening of sterling against the major currencies in which EAH invoices ca 97% of sales, it is anticipated that some foreign exchange benef its will enhance earnings. FYMar17E £59.3m rev and 12.97p EPS. 33xPE. 1.4% yield.
PhotonStar LED Group (PSL.L) 1.89p £3.5m
H1 Jun16 results from the designer and manufacturer of smart LED lighting solutions. Revs down 22% to £2.53m. Loss per share flat at 0.4p. Enters H2 with significantly reduced cost base and major R&D work largely complete. Trading continues to be difficult in the traditional LED and contract assembly businesses. However, further revenue improvement seen in Q3 2016. Although trading is currently below market expectations, H2 is expected to provide a positive contribution to FY results. FyDec16E £7.3m sales. (0.37p) LPS.
Bango (BGO.L) 109p £58.56m
The mobile payments company, has expanded the availability of carrier billing for Microsoft Windows Store. For the first time, users in Finland, Norway and Hungary can make purchases from any Windows 10 device, including their Xbox One consoles, using their mobile phone account. The gaming angle is an interesting one due to the high levels of in app purchases. FY Dec16 Forecasts of £4.8m revenues and £3.8m pre-tax loss.
DX Group (DX.L.L) 19p £38.1m
Further to the July announcement that the Competition and Markets authority had served an initial enforcement order regarding the ‘Legal Post’ acquisition, the CMA has now revoked this order but is continuing to assess the transaction. Legal Post had revenues of £5.2m of revenues in y/e May 2015 vs £297.5m for DX Group for FYJun15. Current year forecasts suggest a PE of 4.6x and a yield of 13.5%
Circle Oil (COP.L) 0.65p £3.67m
The international oil and gas exploration, development and production company, has announced the completion of gas pipeline repairs in Morocco. The repaired pipeline spur was used to transport approximately 30% of the gas produced in the Sebou field, which is owned by Circle Oil Maroc (who operate the field with a working interest of 75%) and a Moroccan Government Agency. The repair was carried out by Circle without incident, on schedule and slightly under budget. Production has restarted through the repaired pipeline.
Science Group (SAG.L) 141.5p £56.6m
The provider of independent advisory and advanced product development services focused on science and technology initiatives, has agreed a new 10 year fixed term loan of £15 million. Phased interest rate swaps will fully hedge the loan resulting in a 10-year fixed EAR of circa 3.4%. (For comparison, the effective interest rate on the 5-year term loan, which was scheduled to expire in 2018, is approximately 3.9%. This loan has been repaid.)
Kennedy Ventures (KENV.L) 3.5p £6.13m
The Investment Company with an interest in the Tantalite Valley Mine (TVM) in Namibia announce that it has been informed by Aftan that the plant upgrade program at the Homestead Project in the TVM is progressing as per management expectations with completion anticipated on schedule. Mining operations have continued, with development proceeding as expected and a sufficient stockpile of 4,000 tonnes of ore is now available for the plant to operate continuously.
SyQic (SYQ.L) p £m
SyQic has had an extension granted by the takeover panel regarding a potential takeover by a concert party including Jamal Hassim the current CEO. The cut off is now 7 October 2016. Positive discussions are continuing. FYDec15 results are yet to be published and the shares remain suspended.
Sabien Technology (SNT.L) 4.5p £1.98m
The manufacturer and supplier of M2G, an energy efficiency technology, has announced a conditional £750k placing at 4p. The funds raised from the Placing will provide Sabien with the capital necessary to continue with its growth strategy for up to 40 M2G pilot projects for the Company’s target client base in FY2017 (vs 35 in FY2016).
Intercede Group 9IGP.L) 91.5p £44.67m
Disappointing trading update from the software and service company specialising in identity, credential management and secure mobility. It has had a slow start to the financial year and is continuing to experience delays in the receipt of anticipated MyID license orders. Year to date trading is below expectations and the prior year. FY revenues expected below £11m. A strong pipeline remains and Intercede continues to make good progress in pursuit of its short to medium term strategic objectives.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.